Patient-Centric Trial Design and Execution
Rare disease clinical trials pose unique challenges, such as recruiting patients from a limited and widely scattered patient pool and addressing travel considerations for patients with limited mobility.
In the latest Pharma’s Almanac article, Juliet Moritz, Senior Vice President, Strategic Solutions and Patient Centricity, Ergomed Clinical Research, outlines Ergomed’s strategy for significantly reducing burdens in rare disease clinical trials. This strategy is centered on deep expertise and a proactive, personalized approach to clinical trial preparation and execution.
Key learnings:
- How to minimize patient and site burdens
- Creating trial designs that meet regulatory restrictions
- Maintaining a personal, patient-centric approach
- Navigating diverse healthcare systems globally
Read the “Passion and Understanding: Essentials for Rare Disease Clinical Trials” article to discover how Ergomed navigates the complexities of rare disease clinical trials.
"*" indicates required fields